Regulation of p21cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase

被引:111
作者
Bottazzi, ME [1 ]
Zhu, XY [1 ]
Böhmer, RM [1 ]
Assoian, RK [1 ]
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
cell cycle; adhesion; ECM; MAP kinase; cdk inhibitors;
D O I
10.1083/jcb.146.6.1255
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have examined the regulation of p21(cip1) by soluble mitogens and cell anchorage as well as the relationship between the expression of p21(cip1) and activation of the ERK subfamily of MAP kinases, We find that p21(cip1) expression in G1 phase can be divided into two discrete phases: an initial induction that requires growth factors and the activation of ERK, and then a subsequent decline that is enhanced by cell anchorage in an ERK-independent manner. In contrast to the induction of cyclin D1, the induction of p21(cip1) is mediated by transient ERK activity. Comparative studies with wild-type and p21(cip1)-null fibroblasts indicate that adhesion-dependent regulation of p21(cip1) is important for proper control of cyclin E-cdk2 activity, These data lead to a model in which mitogens and anchorage act in a parallel fashion to regulate G1 phase expression of p21(cip1) They also show that (a) growth factors and growth factor/extracellular matrix cooperation can have different roles in regulating G1 phase ERK activity and (b) both transient and sustained ERK signals have functionally significant roles in controlling cell cycle progression through G1 phase.
引用
收藏
页码:1255 / 1264
页数:10
相关论文
共 52 条
[11]   Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor E2F pathway [J].
Day, ML ;
Foster, RG ;
Day, KC ;
Zhao, X ;
Humphrey, P ;
Swanson, P ;
Postigo, AA ;
Zhang, SH ;
Dean, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8125-8128
[12]  
ELDEIRY W, 1993, CELL, V75, P518
[13]   Dependence of cyclin E-CDK2 kinase activity on cell anchorage [J].
Fang, F ;
Orend, G ;
Watanabe, N ;
Hunter, T ;
Ruoslahti, E .
SCIENCE, 1996, 271 (5248) :499-502
[14]   Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].
Favata, MF ;
Horiuchi, KY ;
Manos, EJ ;
Daulerio, AJ ;
Stradley, DA ;
Feeser, WS ;
Van Dyk, DE ;
Pitts, WJ ;
Earl, RA ;
Hobbs, F ;
Copeland, RA ;
Magolda, RL ;
Scherle, PA ;
Trzaskos, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632
[15]   Integrin signaling: specificity and control of cell survival and cell cycle progression [J].
Giancotti, FG .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) :691-700
[16]   Translational control of p27(Kip1) accumulation during the cell cycle [J].
Hengst, L ;
Reed, SI .
SCIENCE, 1996, 271 (5257) :1861-1864
[17]   Integrin signaling and cell growth control [J].
Howe, A ;
Aplin, AE ;
Alahari, SK ;
Juliano, RL .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) :220-231
[18]   CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE [J].
HUNTER, T ;
PINES, J .
CELL, 1994, 79 (04) :573-582
[19]  
Kerkhoff E, 1998, CANCER RES, V58, P1636
[20]   New functional activities for the p21 family of CDK inhibitors [J].
LaBaer, J ;
Garrett, MD ;
Stevenson, LF ;
Slingerland, JM ;
Sandhu, C ;
Chou, HS ;
Fattaey, A ;
Harlow, E .
GENES & DEVELOPMENT, 1997, 11 (07) :847-862